Abstract
Nanotechnology in cancer has been a boon to the translational science bringing advantages to the conventional drug delivery approaches. There are different types of nanoparticles such as liposomes, dendrimers, and mesoporous silica nanoparticles that are being employed to improve the overall biodistribution of the drug; however, this often fails in in vivo model due to the lack of stealth property, ultimately leading to immune rejection. PEG, chitosan, etc. are polymeric coatings that have been used as stealth covering around nanoparticles that prevent the nanoparticles from aggregation of proteins and opsonization. However, synthesis of polymeric coatings requires chemistries for conjugation that are often tedious and labor intensive. In this scenario, biomimetic nanoparticles have become convenient as they can be produced without much use of organic solvents. In addition, they can mediate natural targeting due to the virtue of homotypic interaction with membrane proteins present on the host cell. In addition, they can also prevent immune recognition due to the presence of marker proteins that are often recognized as “self” by the body. There have been several achievements in this field; still there are certain limitations that need to be dealt with. Techniques to produce biomimetic nanoparticles in a cost-effective manner in larger batches can lessen the burden in manufacturing process. Biomimetic nanoparticles possess immense benefits with better targeting and stealth property that can reduce the shortcomings of the traditional nanoparticles employed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Tambosi G et al (2018) Challenges to improve the biopharmaceutical properties of poorly water-soluble drugs and the application of the solid dispersion technology. Matéria (Rio de Janeiro) 23
Vrignaud S, Benoit J-P, Saulnier P (2011) Strategies for the nanoencapsulation of hydrophilic molecules in polymer-based nanoparticles. Biomaterials 32(33):8593–8604
Olusanya TOB et al (2018) Liposomal drug delivery systems and anticancer drugs. Molecules 23(4):907
Masood F (2016) Polymeric nanoparticles for targeted drug delivery system for cancer therapy. Mater Sci Eng C 60:569–578
Xu W, Ling P, Zhang T (2013) Polymeric micelles, a promising drug delivery system to enhance bioavailability of poorly water-soluble drugs. J Drug Deliv 2013:340315
Wakaskar R (2017) Polymeric micelles for drug delivery. Int J Drug Dev Res 9:3
Antoni P et al (2009) Bifunctional dendrimers: from robust synthesis and accelerated one-pot postfunctionalization strategy to potential applications. Angew Chem Int Ed Engl 48(12):2126–2130
Shadrack DM, Mubofu EB, Nyandoro SS (2015) Synthesis of polyamidoamine dendrimer for encapsulating tetramethylscutellarein for potential bioactivity enhancement. Int J Mol Sci 16(11):26363–26377
Beddoes CM, Case CP, Briscoe WH (2015) Understanding nanoparticle cellular entry: a physicochemical perspective. Adv Colloid Interf Sci 218:48–68
Price PM et al (2018) Magnetic drug delivery: where the field is going. Front Chem 6(619)
Akbarzadeh A, Samiei M, Davaran S (2012) Magnetic nanoparticles: preparation, physical properties, and applications in biomedicine. Nanoscale Res Lett 7(1):144
Singh P et al (2018) Gold nanoparticles in diagnostics and therapeutics for human cancer. Int J Mol Sci 19(7)
Shahbazi MA, Herranz B, Santos HA (2012) Nanostructured porous Si-based nanoparticles for targeted drug delivery. Biomatter 2(4):296–312
Salmaso S, Caliceti P (2013) Stealth properties to improve therapeutic efficacy of drug nanocarriers. J Drug Deliv 2013:374252
Garcia-Fuentes M et al (2005) A comparative study of the potential of solid triglyceride nanostructures coated with chitosan or poly(ethylene glycol) as carriers for oral calcitonin delivery. Eur J Pharm Sci 25(1):133–143
Garay RP et al (2012) Antibodies against polyethylene glycol in healthy subjects and in patients treated with PEG-conjugated agents. Expert Opin Drug Deliv 9(11):1319–1323
Bludau H et al (2017) POxylation as an alternative stealth coating for biomedical applications. Eur Polym J 88:679–688
Zhang X et al (2019) Trastuzumab-coated nanoparticles loaded with docetaxel for breast cancer therapy. Dose Response 17(3):1559325819872583
Xu S et al (2019) PD-L1 monoclonal antibody-conjugated nanoparticles enhance drug delivery level and chemotherapy efficacy in gastric cancer cells. Int J Nanomedicine 14:17–32
Yoo J et al (2019) Active targeting strategies using biological ligands for nanoparticle drug delivery systems. Cancers (Basel) 11(5)
Poltavets YI et al (2019) In vitro anticancer activity of folate-modified docetaxel-loaded PLGA nanoparticles against drug-sensitive and multidrug-resistant cancer cells. Cancer Nanotechnol 10(1):2
Huo M et al (2017) Tumor-targeted delivery of sunitinib base enhances vaccine therapy for advanced melanoma by remodeling the tumor microenvironment. J Control Release 245:81–94
Mei L et al (2014) Angiopep-2 and activatable cell penetrating peptide dual modified nanoparticles for enhanced tumor targeting and penetrating. Int J Pharm 474(1–2):95–102
Shao K et al (2010) Angiopep-2 modified PE-PEG based polymeric micelles for amphotericin B delivery targeted to the brain. J Control Release 147(1):118–126
Ché C et al (2010) New angiopep-modified doxorubicin (ANG1007) and etoposide (ANG1009) chemotherapeutics with increased brain penetration. J Med Chem 53:2814–2824
Guo J et al (2011) Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery. Biomaterials 32(31):8010–8020
Duan T et al (2019) HPA aptamer functionalized paclitaxel-loaded PLGA nanoparticles for enhanced anticancer therapy through targeted effects and microenvironment modulation. Biomed Pharmacother 117:109121
Li B et al (2018) The potential of biomimetic nanoparticles for tumor-targeted drug delivery. Nanomedicine (Lond) 13(16):2099–2118
Qu N et al (2019) Docetaxel-loaded human serum albumin (HSA) nanoparticles: synthesis, characterization, and evaluation. Biomed Eng Online 18(1):11
Wongsasulak S et al (2010) Electrospinning of food-grade nanofibers from cellulose acetate and egg albumen blends. J Food Eng 98:370–376
Iravani S et al (2014) Synthesis of silver nanoparticles: chemical, physical and biological methods. Res Pharm Sci 9(6):385–406
Zhen Z et al (2013) Ferritin nanocages to encapsulate and deliver photosensitizers for efficient photodynamic therapy against cancer. ACS Nano 7(8):6988–6996
Sanchez-Gaytan BL et al (2015) HDL-mimetic PLGA nanoparticle to target atherosclerosis plaque macrophages. Bioconjug Chem 26(3):443–451
Liu Y et al (2013) Biomimetic enzyme nanocomplexes and their use as antidotes and preventive measures for alcohol intoxication. Nat Nanotechnol 8(3):187–192
Fan T et al (2017) Peptide self-assembled nanostructures for drug delivery applications. J Nanomater 2017:4562474
Dash P, Piras AM, Dash M (2020) Cell membrane coated nanocarriers - an efficient biomimetic platform for targeted therapy. J Control Release 327:546–570
Rao L et al (2017) Microfluidic electroporation-facilitated synthesis of erythrocyte membrane-coated magnetic nanoparticles for enhanced imaging-guided cancer therapy. ACS Nano 11(4):3496–3505
Zhai Y et al (2017) Preparation and application of cell membrane-camouflaged nanoparticles for cancer therapy. Theranostics 7(10):2575–2592
Zhang J et al (2015) Synthesis of nanogels via cell membrane-templated polymerization. Small 11(34):4309–4313
Liu Y et al (2019) Cell membrane coating technology: a promising strategy for biomedical applications. Nano-Micro Lett 11(1):100
Luk BT, Zhang L (2015) Cell membrane-camouflaged nanoparticles for drug delivery. J Control Release 220(Pt B):600–607
Fang RH et al (2014) Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery. Nano Lett 14(4):2181–2188
Hu CM et al (2011) Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc Natl Acad Sci U S A 108(27):10980–10985
Bidkar AP, Sanpui P, Ghosh SS (2020) Transferrin-conjugated red blood cell membrane-coated poly(lactic-co-glycolic acid) nanoparticles for the delivery of doxorubicin and methylene blue. ACS Appl Nano Mater 3(4):3807–3819
Xia Q et al (2019) Red blood cell membrane-camouflaged nanoparticles: a novel drug delivery system for antitumor application. Acta Pharm Sin B 9(4):675–689
Dong Y et al (2018) The survival of fetal and bone marrow monocyte-derived alveolar macrophages is promoted by CD44 and its interaction with hyaluronan. Mucosal Immunol 11(3):601–614
Sun K et al (2020) Saikosaponin D loaded macrophage membrane-biomimetic nanoparticles target angiogenic signaling for breast cancer therapy. Appl Mater Today 18:100505
Pitchaimani A, Nguyen TDT, Aryal S (2018) Natural killer cell membrane infused biomimetic liposomes for targeted tumor therapy. Biomaterials 160:124–137
Han Y et al (2019) T cell membrane mimicking nanoparticles with bioorthogonal targeting and immune recognition for enhanced photothermal therapy. Adv Sci 6(15):1900251
Cao X et al (2019) Neutrophil-mimicking therapeutic nanoparticles for targeted chemotherapy of pancreatic carcinoma. Acta Pharm Sin B 9(3):575–589
Li Z, Hu S, Cheng K (2018) Platelets and their biomimetics for regenerative medicine and cancer therapies. J Mater Chem B 6(45):7354–7365
Song Y et al (2019) Platelet membrane-coated nanoparticle-mediated targeting delivery of Rapamycin blocks atherosclerotic plaque development and stabilizes plaque in apolipoprotein E-deficient (ApoE(−/−)) mice. Nanomedicine 15(1):13–24
Nie D et al (2020) Cancer-cell-membrane-coated nanoparticles with a yolk–Shell structure augment cancer chemotherapy. Nano Lett 20(2):936–946
Gao C et al (2016) Stem cell membrane-coated nanogels for highly efficient in vivo tumor targeted drug delivery. Small 12(30):4056–4062
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Dash, P., Dash, M. (2022). Biomimetic Nanosystems in Targeted Drug Delivery. In: Dash, M. (eds) Biomimetic Biomaterials for Tissue Regeneration and Drug Delivery. Springer, Singapore. https://doi.org/10.1007/978-981-16-4566-2_3
Download citation
DOI: https://doi.org/10.1007/978-981-16-4566-2_3
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-16-4565-5
Online ISBN: 978-981-16-4566-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)